Autonomix Medical Statistics
Total Valuation
AMIX has a market cap or net worth of $15.39 million. The enterprise value is $11.32 million.
Important Dates
The last earnings date was Monday, November 11, 2024, before market open.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AMIX has 1.15 million shares outstanding. The number of shares has increased by 44.85% in one year.
| Current Share Class | 1.15M |
| Shares Outstanding | 1.15M |
| Shares Change (YoY) | +44.85% |
| Shares Change (QoQ) | +20.35% |
| Owned by Insiders (%) | 33.34% |
| Owned by Institutions (%) | 1.59% |
| Float | 646,962 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.08 |
| P/TBV Ratio | 5.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.26, with a Debt / Equity ratio of 0.36.
| Current Ratio | 4.26 |
| Quick Ratio | 4.10 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -67.05 |
Financial Efficiency
Return on equity (ROE) is -27,017.08% and return on invested capital (ROIC) is -1,091.55%.
| Return on Equity (ROE) | -27,017.08% |
| Return on Assets (ROA) | -176.47% |
| Return on Capital (ROIC) | -1,091.55% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.94 |
| 200-Day Moving Average | 35.23 |
| Relative Strength Index (RSI) | 57.07 |
| Average Volume (20 Days) | 1,529,258 |
Short Selling Information
The latest short interest is 100,150, so 8.69% of the outstanding shares have been sold short.
| Short Interest | 100,150 |
| Short Previous Month | 136,093 |
| Short % of Shares Out | 8.69% |
| Short % of Float | 15.48% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.93M |
| Pretax Income | -15.43M |
| Net Income | -14.03M |
| EBITDA | n/a |
| EBIT | -10.93M |
| Earnings Per Share (EPS) | -$15.26 |
Full Income StatementBalance Sheet
The company has $5.16 million in cash and $1.09 million in debt, giving a net cash position of $4.07 million or $3.53 per share.
| Cash & Cash Equivalents | 5.16M |
| Total Debt | 1.09M |
| Net Cash | 4.07M |
| Net Cash Per Share | $3.53 |
| Equity (Book Value) | 3.03M |
| Book Value Per Share | 2.63 |
| Working Capital | 4.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.29 million and capital expenditures -$24,000, giving a free cash flow of -$8.32 million.
| Operating Cash Flow | -8.29M |
| Capital Expenditures | -24,000 |
| Free Cash Flow | -8.32M |
| FCF Per Share | -$7.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |